Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio Growth (5y) (2015 - 2025)
Sonoma Pharmaceuticals (SNOA) Interest Coverage Ratio Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -160.20% |
| Sep 30, 2025 | -66.94% |
| Jun 30, 2025 | -26.54% |
| Mar 31, 2025 | 27.27% |
| Sep 30, 2024 | -0.15% |
| Jun 30, 2024 | -43.83% |
| Mar 31, 2024 | 12.22% |
| Dec 31, 2023 | 40.60% |
| Sep 30, 2023 | 61.78% |
| Jun 30, 2023 | 36.94% |
| Mar 31, 2023 | 15.35% |
| Dec 31, 2022 | 32.77% |
| Sep 30, 2022 | 32.31% |
| Jun 30, 2022 | 24.36% |
| Mar 31, 2022 | 23.46% |
| Dec 31, 2021 | 2.46% |
| Sep 30, 2021 | 78.97% |
| Jun 30, 2021 | 79.96% |
| Dec 31, 2020 | 71.04% |
| Sep 30, 2020 | 15.10% |